Köckerling A, Reinalter S C, Seyberth H W
Department of Pediatrics, Philipps University, Marburg, Germany.
J Pediatr. 1996 Oct;129(4):519-28. doi: 10.1016/s0022-3476(96)70116-6.
In hyperprostaglandin E syndrome (HPS) renal wasting of electrolytes and water is consistently associated with enhanced synthesis of prostaglandin E2. In contrast to Bartter or Gitelman syndrome (BS/GS), HPS is characterized by its severe prenatal manifestation, leading to fetal polyuria, development of polyhydramnios, and premature birth. This disorder mimics furosemide treatment with hypokalemic alkalosis, hypochloremia, isosthenuria, and impaired renal conservation of both calcium and magnesium. Therefore the thick ascending limb of the loop of Henle seems to be involved in HPS. To characterize the tubular defect we investigated the response to furosemide (2 mg/kg) in HPS (n = 8) and BS/GS (n = 3) 1 week after discontinuation of long-term indomethacin treatment. Sensitivity to furosemide was completely maintained in patients with BS/GS. The diuretic, saluretic, and hormonal responses were similar to those of a control group of healthy children (n = 13), indicating an intact function of the thick ascending limb of the loop of Henle in BS/GS. In contrast, patients with HPS had a marked resistance to this loop diuretic. Furosemide treatment increased urine output by 7.5 +/- 0.7 ml/kg per hour in healthy control subjects but only by 4.4 +/- 1.2 ml/kg per hour (p < 0.5) in children with HPS. In parallel, the latter also had a markedly impaired saluretic response (delta Cl(urine) 0.14 +/- 0.04 mmol/kg per hour vs 0.85 +/- 0.09 mmol/kg per hour, p < 0.001; delta Na(urine) 0.23 +/- 0.06 mmol/kg per hour vs 0.77 +/- 0.09 mmol/kg per hour, p < 0.001). Furosemide therapy further enhanced prostaglandin E2 excretion in patients with HPS (54 +/- 17 to 107 +/- 28 ng/hr per 1.73 m2, p < 0.05), whereas no significant effect was observed in healthy children (20 +/- 3 to 12 +/- 3 ng/hr per 1.73 m2). We conclude that a defect of electrolyte reabsorption in the thick ascending limb of the loop of Henle plays a major role in HPS.
在高前列腺素E综合征(HPS)中,电解质和水的肾性丢失始终与前列腺素E2合成增加相关。与巴特综合征或吉特曼综合征(BS/GS)不同,HPS的特征是严重的产前表现,导致胎儿多尿、羊水过多和早产。这种疾病类似于使用呋塞米治疗导致的低钾性碱中毒、低氯血症、等渗尿以及肾脏对钙和镁的保留受损。因此,髓袢升支粗段似乎参与了HPS的发病过程。为了明确肾小管缺陷,我们在长期吲哚美辛治疗停药1周后,研究了HPS患者(n = 8)和BS/GS患者(n = 3)对呋塞米(2 mg/kg)的反应。BS/GS患者对呋塞米的敏感性完全保留。其利尿、利钠和激素反应与健康儿童对照组(n = 13)相似,表明BS/GS患者髓袢升支粗段功能完整。相比之下,HPS患者对这种袢利尿剂有明显抵抗。呋塞米治疗使健康对照受试者的尿量每小时增加7.5±0.7 ml/kg,但HPS患儿仅增加4.4±1.2 ml/kg(p < 0.5)。同时,后者的利钠反应也明显受损(尿氯变化0.14±0.04 mmol/kg每小时 vs 0.85±0.09 mmol/kg每小时,p < 0.001;尿钠变化0.23±0.06 mmol/kg每小时 vs 0.77±0.09 mmol/kg每小时,p < 0.001)。呋塞米治疗进一步增加了HPS患者的前列腺素E2排泄(从每1.73 m2 54±17至107±28 ng/小时,p < 0.05),而在健康儿童中未观察到显著影响(从每1.73 m2 20±3至12±3 ng/小时)。我们得出结论,髓袢升支粗段电解质重吸收缺陷在HPS中起主要作用。